-
"Insulin Maotai" Gan Li pharmaceutical product structure single problem is difficult to solve.
Time of Update: 2020-07-20
In response to the fourth generation of insulin research and development progress and product structure of the single issue, Time Finance on June 16 repeatedly called Gan Li Pharmaceuticals, the other side said it would not comment .
-
GE Medical has a monthly production capacity of up to 1,000 high-end ventilators in China.
Time of Update: 2020-07-20
Pharmaceutical Network, June 23 - Ge Medical, the world's leading provider of medical imaging, monitoring and digital medical technology, announced the successful start-up of the high-end ventilator production line in Wuxi, Jiangsu Province On the same day, the first batch of products will be synchronized offline, these products will help the global anti-epidemic and support the "preventive public health system" construction .
-
Repurchase lost trust, the performance plummeted Dong A gum dilemma to be solved.
Time of Update: 2020-07-20
Pharmaceutical Network, June 23rd, the East A-A-Gum Co., Ltd (hereinafter referred to as "East A-Gum") announced that in order to better play the largest role of funds in the production and operation, the termination of the repurchase of the company's shares This has sparked a market uproar and its reputation has been questioned again .
-
Tianshi Li bet on the pharmaceutical industry.
Time of Update: 2020-07-20
Pharmaceutical Network, June 18, recently announced that Tianshili will sell 1.489 billion yuan to Chongqing Pharmaceuticals Tianshili Marketing 99.9448% of the shares, the sale of funds will be use
-
Yangzijiang into the $1 billion schizophrenic market.
Time of Update: 2020-07-20
Figure 2: Earlier domestic hydrochloric acid Lulasiketone imitation listing declaration Source: Minnet net one-click search -meter net data show that the current domestic hydrochloric acid Lulasiketone tablet listing applications are 4 types of imitation, of which Haizheng Pharmaceuticals, Haussen is currently in the review and approval, Zhengda Tianqing in June to be accepted, Yangzijiang for the fourth declaration of enterprises .
-
Chongqing pharmaceutical company approved 2.4 billion glucocorticoid injection Pfizer half of the remaining?
Time of Update: 2020-07-19
Pharmaceutical Network June 28 - June 23, Chongqing Lemmy Pharmaceuticals issued a notice that recently received the State Drug Administration approved the issuance of injection sodium methyl olere
-
The drug is in the trap of GNC.
Time of Update: 2020-07-18
Pharmaceutical Network July 1st, a bad overseas investment, so that the troubled drug once again into the vortex of public opinion . On June 24, GNC filed for bankruptcy protection in the U.S Bankr
-
This Shandong pharmaceutical company is very strong! Take the 7th over-rated variety.
Time of Update: 2020-07-18
China's public medical institutions terminal clathromycin sales (units: 10,000 yuan) with Xinhua Pharmaceuticals' kramycin tablets through consistency evaluation, the current variety of enterprises have reached 4 , respectively, Dongsun Pharmaceuticals, Modern Pharmaceuticals, Baed Pharmaceuticals, Xinhua Pharmaceuticals According to the list of the third batch of collected varieties circulated, the oral frequently released dosage form (250mg, 500mg) of kramycin is listed .
-
Sansheng Guojian is listed in the core products or face a patent cliff.
Time of Update: 2020-07-17
Pharmaceutical Network July 14th, July 13th, the A-share market 8 shares The number of new shares opened for purchase, such as Delinhai, Lihewei, ShenYi Technology, Core Punk Micro, Sansheng Guojian,
-
On Qilu Huahai, stone medicine ... "grab food" 300 million anti-epileptic drugs.
Time of Update: 2020-07-17
Pharmaceutical Network July 13th, recently, Huahai Pharmaceuticals can be said to be a happy event CDE website shows that, following the July 7 huahai Pharmaceuticals' Alyssakou collapse tablet 3 imi
-
5 billion sugar-lowering god drug people will soon enter the office.
Time of Update: 2020-07-17
Pharmaceutical Network July 14 - Recently, Yichang Renfu Pharmaceuticals' hydrochloric acid metformin slow release tablets (acceptance number CYHS1900194) imitation 3 categories of listing application
-
Junshi Bio has partnered with Revitope to develop a new generation of precision-targeted immunotherapy.
Time of Update: 2020-07-17
Guide: The two sides will work together to develop a "new global" T-cell inset activation cancer therapy with dual antigens as a target !----, Junshi Bio announced today that it has entered into a re
-
Health Yuan intends to introduce Gao Yu as a strategic investor with nearly $2.2 billion.
Time of Update: 2020-07-17
Introduction: After the completion of this issue, Gao Gao accounted for 8.00% of the total number of health yuan shares !---- yesterday, Health Yuan issued the "Health Yuan Pharmaceutical Group Co., L
-
Treasure Island stirs up 6 billion injections that will be the third to be reviewed.
Time of Update: 2020-07-17
Pharmaceutical Network July 13th, July 10, CDE official website shows that Treasure Island Pharmaceuticals hydrochloric acid ammonia broso injection 4 class imitation listing application was accepted
-
Pharmaceutical equipment leader by the agency to raise funds, net purchase of more than 70 million yuan
Time of Update: 2020-07-16
According to data, 195 stocks in the Longhu list from April 22 to June 21 showed the net buying status of institutions, and 24 were net purchases of 100 million by institutions in addition, during t
-
A well-known arms enterprises, the first half of the profit jumped 25 times, up and down 17 times!
Time of Update: 2020-07-16
As of the close of trading on July 13, more than 1,000 companies in Shanghai and Shenzhen have issued half-yearly earnings forecasts, and 244 companies have announced earnings improvements , 159 comp
-
Cologne debuty YBZHAN brand live energy saving, research and development, innovation is key
Time of Update: 2020-07-16
"Pharmaceutical Network Exhibitor News" "2020 ybzhan brand live" large-scale public welfare live activities in the hope of all people finally officially began to prepare! Instrument network also does
-
Xi's "triple strategy" to ensure the integrity of low-temperature storage seals of containers
Time of Update: 2020-07-16
The pharmaceutical industry is emerging with a wave of new high-value biologics thanks to the U.S Food and Drug Administration's (FDA) accelerated approval process these drugs, which need to be stor
-
Shanghai Lu Xiangyi emergency export of 150 nucleic acid testing centrifuges to meet overseas demand
Time of Update: 2020-07-16
"Pharmaceutical network corporate news" epidemic without borders, is the common enemy of mankind, so the epidemic prevention and control also need the unity of the international community to respond
-
Children's drug leading enterprises officially purchased, issue price of 5.19 yuan / share
Time of Update: 2020-07-16
"Pharmaceutical Network Corporate News" Recently, The leading domestic company in the field of pediatric respiratory treatment - Hainan Huluwa Pharmaceutical Group Co., Ltd announced that it will be
